Cargando…

The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin

Among the many cell types useful in developing therapeutic treatments, human amniotic cells from placenta have been proposed as valid candidates. Both human amniotic epithelial and mesenchymal stromal cells, and the conditioned medium generated from their culture, exert multiple immunosuppressive ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magatti, Marta, Vertua, Elsa, Cargnoni, Anna, Silini, Antonietta, Parolini, Ornella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434482/ https://www.ncbi.nlm.nih.gov/pubmed/29562786 http://dx.doi.org/10.1177/0963689717742819

Ejemplares similares

B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells
por: Magatti, Marta, et al.
Publicado: (2020)

Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective
por: Papait, Andrea, et al.
Publicado: (2022)

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as healthy controls
por: Pianta, Stefano, et al.
Publicado: (2015)

Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation
por: Cargnoni, Anna, et al.
Publicado: (2020)

Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest
por: Magatti, Marta, et al.
Publicado: (2012)

Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells
por: Orticelli, Valentina, et al.
Publicado: (2021)

The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine
por: Silini, Antonietta R., et al.
Publicado: (2015)

Immunological and Differentiation Properties of Amniotic Cells Are Retained After Immobilization in Pectin Gel
por: Silini, Antonietta R., et al.
Publicado: (2018)

The Cells and Extracellular Matrix of Human Amniotic Membrane Hinder the Growth and Invasive Potential of Bladder Urothelial Cancer Cells
por: Ramuta, Taja Železnik, et al.
Publicado: (2020)

The Multifaceted Roles of MSCs in the Tumor Microenvironment: Interactions With Immune Cells and Exploitation for Therapy
por: Papait, Andrea, et al.
Publicado: (2020)

Human amnion favours tissue repair by inducing the M1‐to‐M2 switch and enhancing M2 macrophage features
por: Magatti, Marta, et al.
Publicado: (2016)

The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?
por: Magatti, Marta, et al.
Publicado: (2021)

Perinatal Mesenchymal Stromal Cells and Their Possible Contribution to Fetal-Maternal Tolerance
por: Magatti, Marta, et al.
Publicado: (2019)

Mapping of the Human Placenta: Experimental Evidence of Amniotic Epithelial Cell Heterogeneity
por: Centurione, Lucia, et al.
Publicado: (2018)

Amniotic Membrane-Derived Stromal Cells Release Extracellular Vesicles That Favor Regeneration of Dystrophic Skeletal Muscles
por: Sandonà, Martina, et al.
Publicado: (2023)

Characterization of the Conditioned Medium from Amniotic Membrane Cells: Prostaglandins as Key Effectors of Its Immunomodulatory Activity
por: Rossi, Daniele, et al.
Publicado: (2012)

Effect of human amniotic epithelial cells on pro‐fibrogenic resident hepatic cells in a rat model of liver fibrosis
por: Cargnoni, Anna, et al.
Publicado: (2017)

Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine
por: Papait, Andrea, et al.
Publicado: (2020)

Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells
por: Lange-Consiglio, Anna, et al.
Publicado: (2020)

CM from intact hAM: an easily obtained product with relevant implications for translation in regenerative medicine
por: Silini, Antonietta Rosa, et al.
Publicado: (2021)

Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study
por: Bonomi, Arianna, et al.
Publicado: (2015)

Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease
por: Giampà, Carmela, et al.
Publicado: (2018)

Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization
por: Muntiu, Alexandra, et al.
Publicado: (2023)

Perinatal Cells: A Promising COVID-19 Therapy?
por: Papait, Andrea, et al.
Publicado: (2021)

Extracellular Vesicles From Perinatal Cells for Anti-inflammatory Therapy
por: Cargnoni, Anna, et al.
Publicado: (2021)

Mapping of the Human Amniotic Membrane: In Situ Detection of Microvesicles Secreted by Amniotic Epithelial Cells
por: Basile, Mariangela, et al.
Publicado: (2023)

Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis
por: Cargnoni, Anna, et al.
Publicado: (2012)

Placental Cells and Derivatives: Advancing Clinical Translation
por: Silini, Antonietta R., et al.
Publicado: (2018)

Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin
por: Jafari, Ameneh, et al.
Publicado: (2021)

Amniotic Membrane Mesenchymal Cells-Derived Factors Skew T Cell Polarization Toward Treg and Downregulate Th1 and Th17 Cells Subsets
por: Pianta, Stefano, et al.
Publicado: (2014)

miRNA Reference Genes in Extracellular Vesicles Released from Amniotic Membrane-Derived Mesenchymal Stromal Cells
por: Ragni, Enrico, et al.
Publicado: (2020)

Gestational stage affects amniotic epithelial cells phenotype, methylation status, immunomodulatory and stemness properties
por: Barboni, Barbara, et al.
Publicado: (2014)

Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation
por: Maymó, Julieta L., et al.
Publicado: (2018)

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?
por: Magnano, Laura, et al.
Publicado: (2020)

Editorial: MSC-Derived Extracellular Vesicles and Secreted Factors as “Cell-Free” Therapeutic Alternatives in Regenerative Medicine
por: Ragni, Enrico, et al.
Publicado: (2022)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

Systemic immune response in young and elderly patients after traumatic brain injury
por: Magatti, Marta, et al.
Publicado: (2023)

Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues
por: Kmiecik, Gabriela, et al.
Publicado: (2014)

Amniotic membrane‐mesenchymal stromal cells secreted factors and extracellular vesicle‐miRNAs: Anti‐inflammatory and regenerative features for musculoskeletal tissues
por: Ragni, Enrico, et al.
Publicado: (2021)

Editorial: Perinatal Derivatives and the Road to Clinical Translation, Volume I
por: Silini, Antonietta R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kodvmq9qke57opno91qd6lvo2m